Acute Pyelonephritis

Cavorsi, Kenneth; Prabhakar, Priya; Kirby, Cheryl L.

doi:10.1097/ruq.0b013e3181dc7d0b

Cited by 8 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…An objective and quantitative diagnosis of perfusion characteristics is of particular relevance in the follow-up of cancer patients but can also be used for the diagnostic assessment of other pathological changes associated with alterations in tissue perfusion. This applies, for example, to the noninvasive diagnosis of the progression of parenchymal liver disease, liver cirrhosis, and portal hypertension [10,11,12,13,14,15,16] and for the noninvasive evaluation of chronic kidney disease [17,18,19] and subclinical kidney transplant rejection [17,20,21,22,23,24]. There are partially contradictory data regarding the evaluation of inflammatory activity and response to biologic therapy in inflammatory bowel disease [25,26,27,28,29,30,31,32,33,34].…”

Section: Why Do We Need Quantification?mentioning

confidence: 99%

EFSUMB Technical Review – Update 2023: Dynamic Contrast-Enhanced Ultrasound (DCE-CEUS) for the Quantification of Tumor Perfusion

Dietrich,

Correas,

Cui

et al. 2023

Ultraschall Med

View full text Add to dashboard Cite

Dynamic contrast-enhanced ultrasound (DCE-US) is a technique to quantify tissue perfusion based on phase-specific enhancement after the injection of microbubble contrast agents for diagnostic ultrasound. The guidelines of the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) published in 2004 and updated in 2008, 2011, and 2020 focused on the use of contrast-enhanced ultrasound (CEUS), including essential technical requirements, training, investigational procedures and steps, guidance regarding image interpretation, established and recommended clinical indications, and safety considerations. However, the quantification of phase-specific enhancement patterns acquired with ultrasound contrast agents (UCAs) is not discussed here. The purpose of this EFSUMB Technical Review is to further establish a basis for the standardization of DCE-US focusing on treatment monitoring in oncology. It provides some recommendations and descriptions as to how to quantify dynamic ultrasound contrast enhancement, and technical explanations for the analysis of time-intensity curves (TICs). This update of the 2012 EFSUMB introduction to DCE-US includes clinical aspects for data collection, analysis, and interpretation that have emerged from recent studies. The current study not only aims to support future work in this research field but also to facilitate a transition to clinical routine use of DCE-US.

show abstract

Section: Why Do We Need Quantification?mentioning

confidence: 99%

EFSUMB Technical Review – Update 2023: Dynamic Contrast-Enhanced Ultrasound (DCE-CEUS) for the Quantification of Tumor Perfusion

Dietrich,

Correas,

Cui

et al. 2023

Ultraschall Med

View full text Add to dashboard Cite

show abstract

“…3). 11,12 Mild pelvocaliectasis and small amounts of perinephric fluid are nonspecific findings. Occasionally, urothelial thickening or gas in the collecting system or parenchyma may be appreciated, although large amounts of parenchymal gas may completely obscure the kidney.…”

Section: Urosepsismentioning

confidence: 99%